Desloratadine (Clarinex)
Medical Letter on Drugs and Therapeutics 44(1126): 27-28
2002
ISSN/ISBN: 0025-732X PMID: 11941265 Document Number: 549863
Document emailed within 1 workday
Related Documents
Scheinfeld, N. 2002: The new antihistamines--desloratadine and levocetirizine: a review Journal of Drugs in Dermatology: Jdd 1(3): 311-316Buczyłko, K.; Chwała, C.; Zielińska-Bliźniewska, H.; Wagner, A.; Dzwonnik, A. 2005: The influence of desloratadine on course of intermittens allergic rhinitis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 18(104): 133-140
Wang, E.J.; Casciano, C.N.; Clement, R.P.; Johnson, W.W. 2001: Evaluation of the interaction of loratadine and desloratadine with P-glycoprotein Drug Metabolism and Disposition: the Biological Fate of Chemicals 29(8): 1080-1083
Sabbah, A. 2002: The place of new antihistamines in allergy management. Apropos of desloratadine Allergie et Immunologie 34(10): 377-383
Chen, X.J.; Chen, L.L.; Shi, X.; Xie, L.X.; Leng, H.; Ji, J.; Lu, D.D. 2012: The effect of desloratadine on patch test reactions in Chinese patients Asian Pacific Journal of Allergy and Immunology 30(3): 209-213
Kruszewski, J.; Kłos, K.; Sułek, K. 2006: Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 21(125): 443-448
Kłos, K.; Kruszewski, J.; Kruszewski, R.; Sułek, K. 2006: The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 21(125): 449-453